AVADIM HEALTH, INC.

ASHEVILLE, NC · Founded 2013 · CIK 0001614824 · Biotech

Biotherapeutic treatments for immune health and neuromuscular disorders

avadimhealth.com →

Grants: —; No SBIR or STTR on record; Sector median: 1
Raised: $81M; 69 Form D · Jun 2020; 75 months since last filing
Contracts: —; No federal contracts on record
Patents: 1; 0 granted · 1 pending; Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount

Federal ↑Equity ↓

2014201520162017201820192020

Capital and federal award history
Date	Event	Source	Amount
04 Aug 2014	Private capital raised	Form D · SEC	$1,146,446
01 Oct 2014	Private capital raised	Form D · SEC	$669,250
24 Oct 2014	Private capital raised	Form D · SEC	$244,576
05 Dec 2014	Private capital raised	Form D · SEC	$105,000
07 Apr 2015	Private capital raised	Form D · SEC	$1,599,525
17 Jul 2015	Private capital raised	Form D · SEC	$2,165,388
06 Oct 2015	Private capital raised· 1 of 2 same day	Form D · SEC	$2,334,750
06 Oct 2015	Private capital raised· 2 of 2 same day	Form D · SEC	$48,000
22 Jan 2016	Private capital raised	Form D · SEC	$1,940,500
25 Jan 2016	Private capital raised	Form D · SEC	$5,238,048
26 Jan 2016	Private capital raised· 1 of 2 same day	Form D · SEC	$1,489,200
26 Jan 2016	Private capital raised· 2 of 2 same day	Form D · SEC	$50,000
27 Jan 2016	Private capital raised· 1 of 4 same day	Form D · SEC	$10,000
27 Jan 2016	Private capital raised· 2 of 4 same day	Form D · SEC	$35,715
27 Jan 2016	Private capital raised· 3 of 4 same day	Form D · SEC	$647,500
27 Jan 2016	Private capital raised· 4 of 4 same day	Form D · SEC	$32,000
19 Feb 2016	Private capital raised	Form D · SEC	$1,590,380
25 Apr 2016	Private capital raised· 1 of 5 same day	Form D · SEC	$245,650
25 Apr 2016	Private capital raised· 2 of 5 same day	Form D · SEC	$187,500
25 Apr 2016	Private capital raised· 3 of 5 same day	Form D · SEC	$156,000
25 Apr 2016	Private capital raised· 4 of 5 same day	Form D · SEC	$10,667
25 Apr 2016	Private capital raised· 5 of 5 same day	Form D · SEC	$17,500
31 May 2016	Private capital raised· 1 of 2 same day	Form D · SEC	$100,875
31 May 2016	Private capital raised· 2 of 2 same day	Form D · SEC	$2,053,250
08 Jun 2016	Private capital raised· 1 of 2 same day	Form D · SEC	$10,000
08 Jun 2016	Private capital raised· 2 of 2 same day	Form D · SEC	$2,645,140
13 Jun 2016	Private capital raised	Form D · SEC	$1,692
11 Aug 2016	Private capital raised	Form D · SEC	$147,000
12 Aug 2016	Private capital raised· 1 of 3 same day	Form D · SEC	$763,253
12 Aug 2016	Private capital raised· 2 of 3 same day	Form D · SEC	$1,200,000
12 Aug 2016	Private capital raised· 3 of 3 same day	Form D · SEC	$405,998
25 Aug 2016	Private capital raised	Form D · SEC	$2,126,938
31 Aug 2016	Private capital raised	Form D · SEC	$752,335
20 Sept 2016	Private capital raised	Form D · SEC	$917,490
05 Oct 2016	Private capital raised· 1 of 2 same day	Form D · SEC	$493,051
05 Oct 2016	Private capital raised· 2 of 2 same day	Form D · SEC	$1,790,716
08 Nov 2016	Private capital raised	Form D · SEC	$575,896
21 Nov 2016	Private capital raised· 1 of 3 same day	Form D · SEC	$625,740
21 Nov 2016	Private capital raised· 2 of 3 same day	Form D · SEC	$1,045,500
21 Nov 2016	Private capital raised· 3 of 3 same day	Form D · SEC	$1,541,964
02 Dec 2016	Private capital raised	Form D · SEC	$674,016
19 Dec 2016	Private capital raised	Form D · SEC	$587,214
03 Jan 2017	Private capital raised· 1 of 2 same day	Form D · SEC	$251,154
03 Jan 2017	Private capital raised· 2 of 2 same day	Form D · SEC	$5,168
17 Jan 2017	Private capital raised	Form D · SEC	$1,244,324
10 Feb 2017	Private capital raised	Form D · SEC	$1,213,290
16 Feb 2017	Private capital raised· 1 of 2 same day	Form D · SEC	$684,144
16 Feb 2017	Private capital raised· 2 of 2 same day	Form D · SEC	$6,575
17 Mar 2017	Private capital raised	Form D · SEC	$17,000
03 Apr 2017	Private capital raised	Form D · SEC	$588,510
18 Aug 2017	Private capital raised· 1 of 6 same day	Form D · SEC	$4,683
18 Aug 2017	Private capital raised· 2 of 6 same day	Form D · SEC	$10,196
18 Aug 2017	Private capital raised· 3 of 6 same day	Form D · SEC	$250,000
18 Aug 2017	Private capital raised· 4 of 6 same day	Form D · SEC	$22,878
18 Aug 2017	Private capital raised· 5 of 6 same day	Form D · SEC	$2,750,000
18 Aug 2017	Private capital raised· 6 of 6 same day	Form D · SEC	$250,000
12 Oct 2017	Private capital raised· 1 of 2 same day	Form D · SEC	$8,190
12 Oct 2017	Private capital raised· 2 of 2 same day	Form D · SEC	$7,280
16 Apr 2018	Private capital raised	Form D · SEC	$11,755,300
25 Mar 2019	Private capital raised· 1 of 2 same day	Form D · SEC	$6,000
25 Mar 2019	Private capital raised· 2 of 2 same day	Form D · SEC	$425,000
16 Aug 2019	Private capital raised	Form D · SEC	$24,929,752
08 Oct 2019	Private capital raised· 1 of 2 same day	Form D · SEC	$339,338
08 Oct 2019	Private capital raised· 2 of 2 same day	Form D · SEC	$1,390,000
17 Jan 2020	Private capital raised· 1 of 3 same day	Form D · SEC	$9,000
17 Jan 2020	Private capital raised· 2 of 3 same day	Form D · SEC	$30,000
17 Jan 2020	Private capital raised· 3 of 3 same day	Form D · SEC	$35,000
06 Feb 2020	Private capital raised	Form D · SEC	$66,538
23 Jun 2020	Private capital raised	Form D · SEC	$318,750

Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value

Biotech companies ranked by federal contract value
#	Company	Contracts	Disclosed equity
2175	Arena Therapeutics OpCo, Inc.	—	$600K
2176	AFFIRMED PHARMA, LLC	—	—
2177	PARTILLION BIOSCIENCE CORPORATION	—	—
2178	AVADIM HEALTH, INC.	—	$81M
2179	ID4PHARMA, LLC	—	—
2180	ENABLE LIFE SCIENCES LLC	—	—
2181	General Counsel AI, Inc.	—	$63M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 14 related persons

DEWEY ANDREWDirector
HUMBERTO ANTUNESDirector
LOUIS BUCKDirector
PAUL COVIELLODirector
PAUL COXDirector · Executive Officer
DAVID FANNDirector · Executive Officer
JB HOLEMANDirector
RALPH LOMBARDOExecutive Officer
LINDA MCGOLDRICKDirector
JOE MCGUIREExecutive Officer
CHARLES OWENDirector
KARAN RAIDirector
JAMES ROSATIDirector
STEVE WOODYDirector · Executive Officer

Patents

USPTO · 0 granted of 1

—Compositions And Methods For The Antiseptic Treatment Of Biofilms On Mammalian Tissueapplication

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.